Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.
Bravecto 1x1 tab
Chewable tablet for the treatment of tick and flea infestations in dogs.
This veterinary medicinal product is a systemic insecticide and acaricide that provides:
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. The onset of effect is within 8 hours of attachment for fleas (C. felis) and 12 hours of attachment for ticks (I. ricinus). The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
For oral use. Administer at or around the time of feeding.
Bravecto should be administered in accordance with the following table
|
Body weight of dag (kg) |
Strength and number of tablets to be administered |
||||
|
Bravecto 112,5 mg |
Bravecto 250 mg |
Bravecto 500 mg |
Bravecto 1000 mg |
Bravecto 1400 mg |
|
|
2-4,5 |
1 |
|
|
|
|
|
>4,5-10 |
|
1 |
|
|
|
|
>10-20 |
|
|
1 |
|
|
|
>20-40 |
|
|
|
1 |
|
|
>40-56 |
|
|
|
|
1 |
The chewable tablets should not be broken or divided. For dogs above 56 kg bodyweight, use a combination of two tablets that most closely matches the bodyweight
Active ingredient: Fluralaner
| SKU | MSD002 |
|---|---|
| Numéro d'enregistrement | NL: REG NL 116444 |
| Marque | MSD Animal Health |
| Produit réfrigéré | Non |
| Principe Actif | Fluralaner |
| Espèces ciblées | Chien |
| Legal status of supply | UDA |
| Voie d'administration | Orale |
| Units per outer box | 0 |
| Ingrédients | Active ingredient: Fluralaner |